Altravax

Altravax, founded in 2009, is a privately held biopharmaceutical company headquartered in North Dakota with research facilities in Sunnyvale, California. The company is dedicated to the discovery and development of novel products to combat infectious diseases and other conditions. Our proprietary Immunogen Optimization System (IOS) offers a unique opportunity to create new vaccines or improve existing alternatives to meet unmet medical needs. The company has a strong pipeline of candidates at various stages of development, including a therapeutic vaccine for chronic hepatitis B infection and a preventive vaccine for all four dengue viruses. Altravax is seeking strategic alliances to advance these leading candidates into clinical testing.